CVS Health (CVS) ebitda was $9.8B in FY2025 (-30% YoY). The tables below show the complete quarterly and annual ebitda history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual EBITDA
Fiscal Year
EBITDA
YoY
2025
$9.8B
-30%
2024
$13.9B
-27%
2023
$19.0B
+51%
2022
$12.6B
-31%
2021
$18.3B
-3%
2020
$18.8B
+12%
2019
$16.8B
+140%
2018
$7.0B
-44%
2017
$12.5B
-5%
2016
$13.1B
+11%
2015
$11.8B
+8%
2014
$10.9B
+8%
2013
$10.0B
+10%
2012
$9.1B
+13%
2011
$8.0B
+4%
2010
$7.8B
-3%
2009
$8.0B
+8%
2008
$7.4B
+24%
2007
$6.0B
Recent Quarterly EBITDA
Quarter
EBITDA
Q2 2026
$6.0B
Q1 2026
$6.1B
Q4 2025
$3.4B
Q3 2025
-$1.9B
Q2 2025
$3.7B
Q1 2025
$4.7B
Q4 2024
$3.7B
Q3 2024
$2.4B
Q2 2024
$4.3B
Q1 2024
$3.5B
Q4 2023
$6.2B
Q3 2023
$4.4B
Source: CVS on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.